Abstract:Bioactive peptides exhibit key roles in a wide variety of complex processes, such as regulation of body weight, learning, aging, and innate immune response. Next to the classical bioactive peptides, emerging from larger precursor proteins by specific proteolytic processing, a new class of peptides originating from small open reading frames (sORFs) have been recognized as important biological regulators. But their intrinsic properties, specific expression pattern and location on presumed non-coding regions have hindered the full characterization of the repertoire of bioactive peptides, despite their predominant role in various pathways. Although the development of peptidomics has offered the opportunity to study these peptides in vivo, it remains challenging to identify the full peptidome as the lack of cleavage enzyme specification and large search space complicates conventional database search approaches. In this study, we introduce a proteogenomics methodology using a new type of mass spectrometry instrument and the implementation of machine learning tools toward improved identification of potential bioactive peptides in the mouse brain. The application of trapped ion mobility spectrometry (tims) coupled to a time-of-flight mass analyzer (TOF) offers improved sensitivity, an enhanced peptide coverage, reduction in chemical noise and the reduced occurrence of chimeric spectra. Subsequent machine learning tools MS2PIP, predicting fragment ion intensities and DeepLC, predicting retention times, improve the database searching based on a large and comprehensive custom database containing both sORFs and alternative ORFs. Finally, the identification of peptides is further enhanced by applying the post-processing semi-supervised learning tool Percolator. Applying this workflow, the first peptidomics workflow combined with spectral intensity and retention time predictions, we identified a total of 167 predicted sORF-encoded peptides, of which 48 originating from presumed non-coding locations, next to 401 peptides from known neuropeptide precursors, linked to 66 annotated bioactive neuropeptides from within 22 different families. Additional PEAKS analysis expanded the pool of SEPs on presumed non-coding locations to 84, while an additional 204 peptides completed the list of peptides from neuropeptide precursors. Altogether, this study provides insights into a new robust pipeline that fuses technological advancements from different fields ensuring an improved coverage of the neuropeptidome in the mouse brain.

Challenges in computational discovery of bioactive peptides in 'omics data

Integrated De Novo Gene Prediction and Peptide Assembly of Metagenomic Sequencing Data

Ion Mobility Coupled to a Time-of-Flight Mass Analyzer Combined With Fragment Intensity Predictions Improves Identification of Classical Bioactive Peptides and Small Open Reading Frame-Encoded Peptides

Bioprospecting and marine 'omics': surfing the deep blue sea for novel bioactive proteins and peptides

Computational tools for exploring sequence databases as a resource for antimicrobial peptides

The Search for Peptide-Based Therapeutics Using Computational Tools

Bioinformatics tools for the study of bioactive peptides from vegetal sources: evolution and future perspectives

Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides

CSM‐peptides: A computational approach to rapid identification of therapeutic peptides

Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.

Advancement and Prospects of Bioinformatics Analysis for Studying Bioactive Peptides from Food-Derived Protein: Sequence, Structure, and Functions

A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides

Combining mass spectrometry and machine learning to discover bioactive peptides

Computational peptide discovery with a genetic programming approach

Classification of bioactive peptides: a systematic benchmark of models and encodings

Bioinformatic approaches to the identification of novel neuropeptide precursors

Towards the Improved Discovery and Design of Functional Peptides: Common Features of Diverse Classes Permit Generalized Prediction of Bioactivity

Challenges and advances in genome mining of ribosomally synthesized and post-translationally modified peptides (RiPPs)

Screening of Novel Bioactive Peptides from Goat Casein: In Silico to In Vitro Validation

Improved design and screening of high bioactivity peptides for drug discovery

Advances in peptide/protein structure prediction tools and their relevance for structural biology in the last decade